Home › Funds › Trails Edge Capital Partners, LP › TRDA
Trails Edge Capital Partners, LP position in TRDA
ENTRADA THERAPEUTICS INC · Health Care
Trails Edge Capital Partners, LP reported holding 1,428,440 shares of TRDA (ENTRADA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$9.1M, representing 1.30% of its reported portfolio and ranking #27 among its reported holdings. Trails Edge Capital Partners, LP first reported this position in Q3 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Trails Edge Capital Partners, LP's TRDA position evolved
Trails Edge Capital Partners, LP first disclosed a stake in TRDA in Q3 2026 at 1,428,440 shares (US$9.1M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 1.43M | $9.07M | New |
About TRDA and 13F data
TRDA (ENTRADA THERAPEUTICS INC) is a Health Care company. 35 other funds we track also report a position in TRDA — the largest reported positions include BAKER BROS. ADVISORS LP (US$37.3M), 5AM Venture Management, LLC (US$29.9M), Merck & Co., Inc. (US$11.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TRDA
- BAKER BROS. ADVISORS LP 5.07M sh · $37.34M · Q2 2026
- 5AM Venture Management, LLC 4.06M sh · $29.85M · Q2 2026
- Merck & Co., Inc. 1.74M sh · $11.05M · Q3 2026
- MPM BioImpact LLC 1.25M sh · $9.22M · Q2 2026
- TCG Crossover Management, LLC 1.06M sh · $6.73M · Q3 2026
- StepStone Group LP 761.28K sh · $5.60M · Q2 2026
- Lynx1 Capital Management LP 178.61K sh · $1.31M · Q2 2026
More on Trails Edge Capital Partners, LP
FAQ
How long has Trails Edge Capital Partners, LP held TRDA?
Trails Edge Capital Partners, LP has disclosed TRDA holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Trails Edge Capital Partners, LP's current position in TRDA?
As of Q3 2026, Trails Edge Capital Partners, LP holds 1.43M shares of TRDA (ENTRADA THERAPEUTICS INC), valued at $9.07M, representing 1.30% of its reported portfolio and ranking #27.
Has Trails Edge Capital Partners, LP been buying or selling TRDA?
In the latest 13F filing (Q3 2026), Trails Edge Capital Partners, LP newly opened its position in TRDA.
Which other funds hold TRDA?
Other major institutional holders of TRDA include BAKER BROS. ADVISORS LP, 5AM Venture Management, LLC, Merck & Co., Inc., among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.